Pulmonary Nodule Cohort
Not yet recruiting
- Conditions
- Pulmonary Nodule, SolitaryLung Cancer
- Registration Number
- NCT04049422
- Lead Sponsor
- Seoul National University Hospital
- Brief Summary
The aim of this study is to identify the clinical features of pulmonary nodules and establish a cohort to identify biomarkers for lung cancer.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 1000
Inclusion Criteria
-
age >= 18
-
pulmonary nodule(s) on chest CT, which satisfy at least one of the following two criteria,
- 4A or above in Lung-RADS v1.1
- lung cancer risk >= 5% in Brock model
Exclusion Criteria
- already proven lung cancer
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of lung cancer up to 5 years incidence of pathologically proven lung cancer
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What biomarkers are being investigated in NCT04049422 for early detection of lung cancer in pulmonary nodule patients?
How does the Pulmonary Nodule Cohort study contribute to understanding molecular mechanisms of nodule progression to malignancy?
Are there comparative studies evaluating the effectiveness of biomarker-guided surveillance versus standard imaging protocols for solitary pulmonary nodules?
What adverse events are associated with biomarker-based diagnostic approaches in lung cancer screening and how are they managed?
What drug classes or molecular targets are currently under investigation for combination therapies in early-stage lung cancer following biomarker identification?